Description
Lantus SoloStar 100 IU/ml 3mL 5’s (Sanofi) is a pre-filled insulin pen containing insulin glargine, a long-acting insulin analog used to manage blood glucose levels in individuals with type 1 and type 2 diabetes mellitus. This formulation provides a steady, basal insulin release over 24 hours, helping to control blood sugar levels throughout the day and night.
Key Features:
-
Concentration: 100 units/mL (U-100)
-
Total Volume: 3 mL per pen
-
Pack Size: 5 pens per box
-
Administration: Subcutaneous injection once daily at the same time each day
-
Storage: Unopened pens should be refrigerated (2°C–8°C); opened pens can be stored at room temperature (below 30°C) for up to 28 days. Do not freeze.
Usage Instructions:
-
Injection Sites: Administer subcutaneously in the abdomen, thigh, or upper arm.
-
Injection Technique: Rotate injection sites to reduce the risk of lipodystrophy and localized cutaneous amyloidosis.
-
Mixing: Do not dilute or mix with other insulins or solutions to maintain the intended pharmacokinetic profile.
Precautions:
-
Hypoglycemia Risk: Monitor blood glucose levels regularly, especially during changes in diet, physical activity, or insulin regimen.
-
Medication Errors: Always verify the insulin label before each injection to prevent mix-ups with other insulin products.
-
Storage: Protect from direct heat and light; do not freeze. Discard if previously frozen.
Indications:
-
Type 1 Diabetes: Provides basal insulin coverage.
-
Type 2 Diabetes: Used alone or in combination with oral antidiabetic agents to control blood glucose levels.
Contraindications:
-
Hypersensitivity: Contraindicated in individuals with known hypersensitivity to insulin glargine or any of its excipients.
-
Hypoglycemia: Not to be used during episodes of hypoglycemia.
Adverse Reactions:
-
Common: Hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema, and weight gain.
Note: This medication is available by prescription only. Always consult with a healthcare professional before initiating or adjusting insulin therapy.
Reviews
There are no reviews yet.